Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2878725 | 0.80 | TSHR (0.33) | TDP1ALDH1A1TSHR | |
| SCHEMBL1350340 | 0.76 | LMNA (0.55) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL9248722 | 0.75 | LMNA (0.48) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL8791083 | 0.75 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL548215 | 0.75 | KMT2A (0.48) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL10886670 | 0.72 | LMNA (0.50) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL11666236 | 0.72 | IDO1 (0.46) | LMNATSHR | |
| SCHEMBL548497 | 0.72 | MEN1 (0.44) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL2781560 | 0.72 | SLC6A2 (0.45) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL17103416 | 0.72 | KMT2A (0.44) | LMNAKMT2AMEN1THRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559884-B2 | Binder-consolidated textile fabric, method for its manufacture and its use | JOHNS MANVILLE (US) | 2026-02-24 | — | — | US | disclosed |
| EP-3299514-B1 | BINDER-CONSOLIDATED TEXTILE FABRIC, METHOD FOR ITS MANUFACTURE AND ITS USE | JOHNS MANVILLE EUROPE GMBH (DE) | 2024-11-06 | — | — | EP | disclosed |
| CN-110835506-B | Adhesive-reinforced textile fabric, method for the production thereof and use thereof | 约翰斯曼维尔公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-107869054-B | Adhesive-reinforced textile, method for the production thereof and use thereof | 约翰斯曼维尔欧洲有限公司 | 2022-05-03 | — | — | CN | disclosed |
| EP-3779015-B1 | BINDER-CONSOLIDATED TEXTILE FABRIC, METHOD FOR ITS MANUFACTURE AND ITS USE | JOHNS MANVILLE (US) | 2021-12-08 | — | — | EP | disclosed |
| US-10934460-B2 | Binder-consolidated textile fabrics and methods of their manufacture and use | JOHNS MANVILLE (US) | 2021-03-02 | — | — | US | disclosed |
| EP-3779015-A1 | BINDER-CONSOLIDATED TEXTILE FABRIC, METHOD FOR ITS MANUFACTURE AND ITS USE | Johns Manville (US) | 2021-02-17 | — | — | EP | disclosed |
| CN-110835506-A | Adhesive-reinforced textile fabric, method for the production thereof and use thereof | 约翰斯曼维尔公司 | 2020-02-25 | — | — | CN | disclosed |
| US-20200056327-A1 | Binder-consolidated textile fabric, method for its manufacture and its use | JOHNS MANVILLE | 2020-02-20 | — | — | US | disclosed |
| US-10472546-B2 | Binder-consolidated textile fabrics and methods of their manufacture and use | JOHNS MANVILLE (US) | 2019-11-12 | — | — | US | disclosed |
| US-20180086951-A1 | BINDER-CONSOLIDATED TEXTILE FABRICS AND METHODS OF THEIR MANUFACTURE AND USE | JOHNS MANVILLE | 2018-03-29 | — | — | US | disclosed |
| EP-3299514-A1 | BINDER-CONSOLIDATED TEXTILE FABRIC, METHOD FOR ITS MANUFACTURE AND ITS USE | Johns Manville Europe GmbH (DE) | 2018-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559884-B2 | Binder-consolidated textile fabric, method for its manufacture and its use | SEM1, SMCHD1, SMC4 | LMNA 990/4885KMT2A 1509/4885MEN1 1256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.